Medicare Enrolled
Dr. Andrew Lerman, M.D.
Neurology · Miami, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lerman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lerman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lerman
Dr. Andrew Lerman is a neurology specialist in Miami, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Lerman performed 10,975 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lerman received a total of $220,298 from 72 pharmaceutical and/or device companies across 1458 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lerman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 10% volume in FL
$220,298 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 123507 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗10,975
Medicare services
Top 10% in FL for neurology
Not available
Unique patients (not deduplicated)
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
9,351 | $5 | $24 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
958 | $144 | $788 |
| New patient office visit, complex (60-74 min) | 155 | $177 | $976 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
96 | $51 | $280 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 92 | $227 | $1,021 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
85 | $366 | $1,914 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
82 | $97 | $562 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
55 | $176 | $960 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $136 | $730 |
| Annual depression screening | 28 | $19 | $77 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
22 | $207 | $1,116 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
13 | $304 | $1,599 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$220,298
Total received (2018-2024)
Avg $31,471/year across 7 years
Top 3% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
1,458
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$64,854
2023
$68,910
2022
$28,695
2021
$13,188
2020
$5,741
2019
$16,222
2018
$22,689
Payments by company (2024)
Neurocrine Biosciences, Inc.
$30,585
ARGENX US, INC.
$9,573
ABBVIE INC.
$6,181
SCILEX PHARMACEUTICALS INC.
$3,987
MDD US Operations, LLC
$3,814
Neurelis, Inc.
$3,585
UCB, Inc.
$3,176
Abbott Laboratories
$1,627
Amneal Pharmaceuticals LLC
$298
PFIZER INC.
$281
Lilly USA, LLC
$280
JAZZ PHARMACEUTICALS INC.
$253
Takeda Pharmaceuticals U.S.A., Inc.
$187
Lundbeck LLC
$112
Sumitomo Pharma America, Inc.
$106
Teva Pharmaceuticals USA, Inc.
$101
Alexion Pharmaceuticals, Inc.
$91
Acorda Therapeutics, Inc
$89
Kyowa Kirin, Inc.
$84
SK Life Science, Inc.
$76
Novartis Pharmaceuticals Corporation
$53
Otsuka America Pharmaceutical, Inc.
$46
Boston Scientific Corporation
$46
Octapharma USA, Inc.
$45
Biogen, Inc.
$45
AstraZeneca Pharmaceuticals LP
$25
Celgene Corporation
$24
ACADIA Pharmaceuticals Inc
$23
LivaNova USA, Inc.
$22
BANNER LIFE SCIENCES, LLC
$22
Merz Pharmaceuticals, LLC
$17
Top 3 companies account for 71.5% of 2024 payments
All-time payments by company (2018-2024) ›
Neurocrine Biosciences, Inc.
$78,641
Amneal Pharmaceuticals LLC
$23,791
ARGENX US, INC.
$22,456
Neurelis, Inc.
$17,598
ABBVIE INC.
$14,358
Sunovion Pharmaceuticals Inc.
$14,081
UCB, Inc.
$7,078
Supernus Pharmaceuticals, Inc.
$6,685
Neurocrine BioSciences, Inc.
$5,600
SCILEX PHARMACEUTICALS INC.
$3,987
MDD US Operations, LLC
$3,814
EISAI INC.
$2,677
Eisai Inc.
$2,600
Abbott Laboratories
$2,302
UPSHER-SMITH LABORATORIES LLC
$994
Novartis Pharmaceuticals Corporation
$932
Allergan, Inc.
$854
SK Life Science, Inc.
$786
Teva Pharmaceuticals USA, Inc.
$783
JAZZ PHARMACEUTICALS INC.
$762
Biohaven Pharmaceuticals, Inc.
$693
PFIZER INC.
$666
Adamas Pharmaceuticals, Inc.
$624
Biogen, Inc.
$601
Greenwich Biosciences, Inc.
$596
Acorda Therapeutics, Inc
$560
Allergan Inc.
$549
Lilly USA, LLC
$542
Lundbeck LLC
$344
Biohaven Pharmaceutical Holding Company Ltd.
$324
Kyowa Kirin, Inc.
$309
Takeda Pharmaceuticals U.S.A., Inc.
$268
Amgen Inc.
$267
Upsher-Smith Laboratories LLC
$256
GENZYME CORPORATION
$193
IMPEL PHARMACEUTICALS INC.
$189
Alexion Pharmaceuticals, Inc.
$168
Avion Pharmaceuticals
$168
CSL Behring
$156
LivaNova USA, Inc.
$154
Scilex Pharmaceuticals Inc.
$142
ACADIA Pharmaceuticals Inc
$141
AbbVie Inc.
$120
Impax Laboratories, Inc.
$115
Sumitomo Pharma America, Inc.
$106
Avanir Pharmaceuticals, Inc.
$96
Alfasigma USA, Inc.
$89
Harmony Biosciences LLC
$89
Octapharma USA, Inc.
$79
GE HEALTHCARE
$78
AQUESTIVE THERAPEUTICS, INC.
$77
Otsuka America Pharmaceutical, Inc.
$70
GRT US Holding, Inc.
$65
BANNER LIFE SCIENCES, LLC
$64
MITSUBISHI TANABE PHARMA AMERICA, INC.
$62
Alnylam Pharmaceuticals Inc.
$52
Boston Scientific Corporation
$46
AstraZeneca Pharmaceuticals LP
$41
Life Molecular Imaging Ltd
$40
Merz Pharmaceuticals, LLC
$38
Grifols USA, LLC
$37
Promius Pharma LLC
$34
Vertical Pharmaceuticals, LLC
$34
Almatica Pharma LLC
$30
Corium, LLC
$24
Celgene Corporation
$24
Medtronic, Inc.
$20
Averitas Pharma Inc.
$20
Aprecia Pharmaceuticals, LLC
$19
Janssen Pharmaceuticals, Inc
$19
Strongbridge US INC.
$14
Electronic Waveform Lab, Inc.
$13
Top 3 companies account for 56.7% of all-time payments
Associated products mentioned in payments ›
ACTIVA PC · ADD-VANTAGE · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · COMIRNATY · COPAXONE · Cenobamate · DUOPA · Dhivy · ELIQUIS · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Epidiolex · Fintepla · Fycompa · GOCOVRI · Gamunex-C · Gocovri · HYQVIA · Hizentra · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LORZONE · LYRICA · Leqembi · MAYZENT · NAMZARIC · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · Ponvory · QULIPTA · QUTENZA · Qutenza · RADICAVA · REXULTI · REYVOW · RYTARY · Rystiggo · SOLIRIS · SYMPAZAN · Spritam · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAINUA · WAKIX · Xeomin · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZTLido · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
269
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
DOCTORS HOSPITAL
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lerman is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lerman experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Lerman performed 9,351 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lerman receive payments from pharmaceutical companies?
Yes. Dr. Lerman received a total of $220,298 from 72 companies across 1,458 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lerman's costs compare to other neurologists in Miami?
Dr. Lerman's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lerman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Miami
Browse neurologists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
Amneal Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Amneal Pharmaceuticals LLC.
By company
ARGENX US, INC. Payments to Doctors
See all physicians who received payments from ARGENX US, INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology